98 related articles for article (PubMed ID: 21693550)
1. Clinically unintended medication switches and inability to prescribe preferred medications under Medicare Part D.
West JC; Rae DS; Mojtabai R; Rubio-Stipec M; Kreyenbuhl JA; Alter CL; Crystal S
J Psychopharmacol; 2012 Jun; 26(6):784-93. PubMed ID: 21693550
[TBL] [Abstract][Full Text] [Related]
2. First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients.
West JC; Wilk JE; Rae DS; Muszynski IL; Rubio-Stipec M; Alter CL; Sanders KE; Crystal S; Regier DA
J Clin Psychiatry; 2010 Apr; 71(4):400-10. PubMed ID: 19925748
[TBL] [Abstract][Full Text] [Related]
3. Medication access and continuity: the experiences of dual-eligible psychiatric patients during the first 4 months of the Medicare prescription drug benefit.
West JC; Wilk JE; Muszynski IL; Rae DS; Rubio-Stipec M; Alter CL; Narrow WE; Regier DA
Am J Psychiatry; 2007 May; 164(5):789-96. PubMed ID: 17475738
[TBL] [Abstract][Full Text] [Related]
4. Estimating Medicare Part D's impact on medication access among dually eligible beneficiaries with mental disorders.
Donohue JM; Frank RG
Psychiatr Serv; 2007 Oct; 58(10):1285-91. PubMed ID: 17914004
[TBL] [Abstract][Full Text] [Related]
5. Medicare Part D prescription drug benefits and administrative burden in the care of dually eligible psychiatric patients.
Wilk JE; West JC; Rae DS; Rubio-Stipec M; Chen JJ; Regier DA
Psychiatr Serv; 2008 Jan; 59(1):34-9. PubMed ID: 18182537
[TBL] [Abstract][Full Text] [Related]
6. Medicaid prescription drug policies and medication access and continuity: findings from ten states.
West JC; Wilk JE; Rae DS; Muszynski IS; Stipec MR; Alter CL; Sanders KE; Crystal S; Regier DA
Psychiatr Serv; 2009 May; 60(5):601-10. PubMed ID: 19411346
[TBL] [Abstract][Full Text] [Related]
7. Part D and dually eligible patients with mental illness: medication access problems and use of intensive services.
Huskamp HA; West JC; Rae DS; Rubio-Stipec M; Regier DA; Frank RG
Psychiatr Serv; 2009 Sep; 60(9):1169-74. PubMed ID: 19723730
[TBL] [Abstract][Full Text] [Related]
8. Impact of Medicare Part D on mental health treatment and outcomes for dual eligible beneficiaries with HIV.
Belenky N; Pence BW; Cole SR; Dusetzina SB; Edmonds A; Oberlander J; Plankey M; Adedimeji A; Wilson TE; Cohen J; Cohen MH; Milam JE; Adimora AA
AIDS Care; 2019 Apr; 31(4):505-512. PubMed ID: 30189747
[TBL] [Abstract][Full Text] [Related]
9. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
10. Effects of Medicare Part D on drug affordability and use: Are seniors with prior high out-of-pocket drug spending affected more?
Mott DA; Thorpe JM; Thorpe CT; Kreling DH; Gadkari AS
Res Social Adm Pharm; 2010 Jun; 6(2):90-9. PubMed ID: 20511108
[TBL] [Abstract][Full Text] [Related]
11. Suicidality is associated with medication access problems in publicly insured psychiatric patients.
MoĊcicki EK; West JC; Rae DS; Rubio-Stipec M; Wilk JE; Regier DA
J Clin Psychiatry; 2010 Dec; 71(12):1657-63. PubMed ID: 21190639
[TBL] [Abstract][Full Text] [Related]
12. Transition to Medicare Part D: an early snapshot of barriers experienced by younger dual eligibles with disabilities.
Hall JP; Kurth NK; Moore JM
Am J Manag Care; 2007 Jan; 13(1):14-8. PubMed ID: 17227199
[TBL] [Abstract][Full Text] [Related]
13. Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage.
Simoni-Wastila L; Zuckerman IH; Shaffer T; Blanchette CM; Stuart B
Health Serv Res; 2008 Apr; 43(2):496-514. PubMed ID: 18370965
[TBL] [Abstract][Full Text] [Related]
14. Dual eligibles with mental disorders and Medicare part D: how are they faring?
Donohue JM; Huskamp HA; Zuvekas SH
Health Aff (Millwood); 2009; 28(3):746-59. PubMed ID: 19414883
[TBL] [Abstract][Full Text] [Related]
15. Impact of the Medicare modernization act on dually eligible persons with psychiatric diagnoses: a New York State case study.
Jones K; Siegel C; Bertollo DN; Samuels J
Psychiatr Serv; 2009 Apr; 60(4):512-9. PubMed ID: 19339327
[TBL] [Abstract][Full Text] [Related]
16. Should psychiatrists lie to access suitable treatment for their patients?
Drew L
Australas Psychiatry; 2004 Mar; 12(1):82. PubMed ID: 15715748
[No Abstract] [Full Text] [Related]
17. Access to prescription drugs for Medicare beneficiaries.
Reschovsky JD; Felland LE
Track Rep; 2009 Mar; (23):1-4. PubMed ID: 19320086
[TBL] [Abstract][Full Text] [Related]
18. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
[TBL] [Abstract][Full Text] [Related]
19. Effect of Medicare Part D and insurance type on Medicare beneficiary access to prescription medication and use of prescription cost-saving measures.
Urmie JM; Farris KB; Doucette WR; Goedken AM
J Am Pharm Assoc (2003); 2011; 51(1):72-81. PubMed ID: 21247829
[TBL] [Abstract][Full Text] [Related]
20. Review of outcomes associated with restricted access to atypical antipsychotics.
Rajagopalan K; Hassan M; Boswell K; Sarnes E; Meyer K; Grossman F
Am J Manag Care; 2016 Jun; 22(6):e208-14. PubMed ID: 27355908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
